Minimally Invasive Aortic Valve Replacement Versus Aortic Valve Replacement Through Full Sternotomy: The Brigham and Women’s Hospital Experience
Critics of mini AVR have called for additional evidence with direct comparison to aortic valve replacement (AVR) via full sternotomy (FS).
Ministernotomy Versus Conventional Sternotomy for Aortic Valve Replacement: Matched Propensity Score Analysis of 808 Patients
This study aimed to perform a risk-adjusted comparison of mortality, rate of stroke and perioperative morbidity of aortic valve replacement (AVR) conducted through either partial mini-sternotomy or conventional sternotomy.
Trainees Can Learn Minimally Invasive Aortic Valve Replacement Without Compromising Safety
Our aim was to assess the impact of trainee performance on short-term outcomes of patients undergoing elective and urgent Mini-AVR where a significant proportion were performed by trainees.
Minimally Invasive Aortic Valve Replacement Provides Equivalent Outcomes at Reduced Cost Compared with Conventional Aortic Valve Replacement: A Real-World Multi-Institutional Analysis
We compared contemporary outcomes and cost of aortic valve replacement (mini-AVR) versus conventional AVR in a multi-institutional regional cohort.
Minimally Invasive Valve Sparing Aortic Root Replacement (David Procedure) is Safe
The purpose of this pilot study was to assess the safety and feasibility of valve sparing aortic root replacement via an upper mini-sternotomy up to the 3(rd) intercostal space.
Randomized Trial of HTK Versus Warm Blood Cardioplegia for Right Ventricular Protection in Mitral Surgery
The objective of this study is to clarify the reliability of the one-shot histidine-tryptophane-ketoglutarate (HTK) cardioplegia for right ventricular (RV) myocardial protection during mitral surgery, in patients with or without pre-operative RV dysfunction.
Myocardial Protection in Donor Heart Preservation: A Comparison Between Bretschneider’s Histidine-Tryptophan-Ketoglutarate Solution and Cold Blood Cardioplegia
This study aimed to compare the efficacy of myocardial protection using single dose of Bretschneider's histidine-tryptophan-ketoglutarate (HTK) solution and repeated doses of cold blood cardioplegia (CBC) in donor heart preservation.
Comparative Experimental Study of Myocardial Protection with Crystalloid Solutions for Heart Transplantation
The objective of this study was to compare the efficacy of myocardial protection solution using both intracellular and extracellular crystalloid type regarding the performance of the electrical conduction system, left ventricular contractility and edema, after being subjected to ischemic arrest and reperfusion.
Acute Hyponatremia after Cardioplegia by Histidine-Tryptophane-Ketoglutarate–A Retrospective Study
We aimed to determine the impact of histidine-tryptophane-ketoglutarate (HTK) infusion on electrolyte and acid-base balance.
A Modified Technique for Implantation of the HeartWare™ Left Ventricular Assist Device When Using Bivalirudin Anticoagulation in Patients with Acute Heparin-Induced Thrombocytopenia
We report here a modified surgical strategy for the implantation of the HeartWare™ left ventricular assist device, which avoids prolonged disconnection of the blood-filled device from the systemic blood flow, so that bivalirudin can be safely used as anticoagulant.
A VAD and Novel High Performance Compact Oxygenator for Long-Term ECMO with Local Anticoagulation
Regional anticoagulant therapy was successfully achieved with a significant difference of activated clotting time between the blood samples from the systemic circulation and those from the ECMO circuit.
Thrombelastography Change after Bridging to Left Ventricular Assist Device from Extracorporeal Membrane Oxygenation Patients
The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received extracorporeal membrane oxygenation (ECMO) and bridged ventricular assist device (VAD) thereafter.